Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hydroxyapatite is the main mineral component of tooth enamel, consisting of crystalline calcium phosphate (Ca₁₀(PO₄)₆(OH)₂), which comprises roughly 95–98% of enamel by weight. Demineralized enamel hydroxyapatite refers to hydroxyapatite whose crystalline structure has been partially dissolved by exposure to acid, leading to loss of calcium and phosphate ions which weakens the enamel and increases susceptibility to dental caries. While not a receptor or protein, demineralized enamel hydroxyapatite is the substrate targeted by remineralizing agents such as fluoride and synthetic hydroxyapatite, which help restore mineral content and improve enamel resistance to acid. Hydroxyapatite is highly biocompatible, and synthetic forms are used in dentistry to aid in mineral repair, reduce sensitivity, and prevent caries.
Not applicable as a canonical target; however, topical agents act by remineralizing hydroxyapatite crystals or substituting ions (e.g., fluoride converts hydroxyapatite to fluorapatite for acid resistance)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite (in demineralized dental enamel) (HA (hydroxyapatite)).